Magnetic hyperthermia therapy enhances the chemoradiosensitivity of glioblastoma

Abstract Glioblastoma (GBM) is the most common primary brain cancer and is resistant to standard-of-care chemoradiation therapy (CRT). Magnetic hyperthermia therapy (MHT) exposes magnetic iron oxide nanoparticles (MIONPs) to an alternating magnetic field (AMF) to generate local hyperthermia. This st...

Cijeli opis

Bibliografski detalji

Glavni autori:	Daniel Rivera, Alexandros Bouras, Milena Mattioli, Maria Anastasiadou, Anna Chiara Pacentra, Olivia Pelcher, Corrine Koziel, Alexander J. Schupper, Tori Chanenchuk, Hayden Carlton, Robert Ivkov, Constantinos G. Hadjipanayis
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2025-03-01
Serija:	Scientific Reports
Teme:	Glioblastoma Magnetic hyperthermia therapy Magnetic iron-oxide nanoparticles Radiation therapy Temozolomide Chemoradiation
Online pristup:	https://doi.org/10.1038/s41598-025-95544-3
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!